Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.9B | 7.0B | 6.8B | 6.8B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.8B | 2.8B | 2.8B | 2.8B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.2B | 2.1B | 2.1B | 2.1B |
Tax provision | 443M | 438M | 350M | 445M |
Net income | 1.7B | 1.7B | 1.7B | 1.6B |
Basic EPS | 1.0 | 1.0 | 1.0 | 1.0 |
Diluted EPS | 1.0 | 1.0 | 1.0 | 1.0 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.7B | 1.7B | 1.7B | 1.6B |
Minority interests | -7M | -7M | -8M | -8M |
Preferred stock dividends | 11M | 10M | 10M | 10M |